Level Chart

Basic Info

Becton Dickinson and Co (BDX) - Biosciences Revenue is at a current level of 375.00M, down from 405.00M last quarter and up from 349.00M one year ago. This is a change of -7.41% from last quarter and 7.45% from one year ago.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 375.00M
Latest Period Dec 2023
Last Updated Apr 30 2024, 08:41 EDT
Next Release Jul 31 2024, 08:30 EDT (E)
Average Growth Rate 5.72%
Value from Last Quarter 405.00M
Change from Last Quarter -7.41%
Value from 1 Year Ago 349.00M
Change from 1 Year Ago 7.45%
Frequency Quarterly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
December 31, 2023 375.00M
September 30, 2023 405.00M
June 30, 2023 368.00M
March 31, 2023 386.00M
December 31, 2022 349.00M
September 30, 2022 358.00M
June 30, 2022 348.00M
March 31, 2022 335.00M
December 31, 2021 338.00M
Date Value
September 30, 2021 352.00M
June 30, 2021 316.00M
March 31, 2021 325.00M
December 31, 2020 312.00M
September 30, 2020 303.00M
June 30, 2020 237.00M
March 31, 2020 280.00M
December 31, 2019 323.00M

Basic Info

Becton Dickinson and Co (BDX) - Biosciences Revenue is at a current level of 375.00M, down from 405.00M last quarter and up from 349.00M one year ago. This is a change of -7.41% from last quarter and 7.45% from one year ago.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 375.00M
Latest Period Dec 2023
Last Updated Apr 30 2024, 08:41 EDT
Next Release Jul 31 2024, 08:30 EDT (E)
Average Growth Rate 5.72%
Value from Last Quarter 405.00M
Change from Last Quarter -7.41%
Value from 1 Year Ago 349.00M
Change from 1 Year Ago 7.45%
Frequency Quarterly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
BDX Becton Dickinson & Co 1.50%